Vizgen
Phil Gardella currently serves as the Chief Financial Officer for Syntis Bio and previously held the same position at Vizgen, Inc., Sherlock Biosciences, Ultivue Inc., Arbor Biotechnologies, Inc., 908 Devices Inc., Quanterix, Bluesocket, Inc., and PowerSteering Software, Inc. Phil also works as a part-time Consulting CFO at Port CFO Solutions, LLC. Phil holds an MBA in Finance from Babson F.W. Olin Graduate School of Business and a BS in Accounting from Northeastern University.
This person is not in any offices
Vizgen
1 followers
Vizgen is the life sciences company developing the next generation of Spatially Resolved Transcriptomics.